Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Buzz on the Bullboards: Investor caution impacts market activity

The TSX began the week on a high note, buoyed by strength in the financial and industrial sectors. However, by Tuesday, the market had slipped into the red, as investor caution took hold ahead of the upcoming U.S. inflation data. Luckily for investors, things rebounded si...
Jonathon Brown | 7 days ago |

Buzz on the Bullboards: Planes, trains and (electric) automobiles

This week, Canada’s main stock index experienced a broad-based rally, pushing the TSX to a new intraday record high on Monday. The energy sector initially led the charge, but falling crude prices and disappointing quarterly results from major domestic bank...
Jonathon Brown | August 29, 2024 |

Buzz on the Bullboards: Three newsmakers during TSX’s rebound

The TSX experienced a roller-coaster week, starting with notable losses but ending with a robust rebound, leading to significant gains. This positive shift has supported investor confidence, proving that it is important to stay updated with recent developments. Let&CloseC...
Jonathon Brown | August 1, 2024 |

Buzz on the Bullboards: Cyanide, Bombardier and healthcare AI

Investors seem to be keeping their money at home this summer, given how the markets have performed in Toronto and New York. In New York, the Nasdaq and the S&P 500 reached new trading highs on more than one occasion in the past few days alone. This was driven by stron...
Jonathon Brown | July 11, 2024 |

Explorer's gold standard team presents a ground floor opportunity

The following is a transcription of the above video, and The Market Online has edited it for clarity . Pinnacle Silver & Gold Corp. (TSXV:PINN) is an exploration stage company engaged in the identification, acquisition, exploration, and development of precious and ...
Ryan Dhillon | June 18, 2024 |

A Portuguese feast: EuroPacific Metals (EUP.V) digs in on a copper and gold smorgasbord

By Chris Parry Two things have changed about Canadian dinner parties over the last few years. The first is, people are less inclined to bring a sassy red and more inclined to bring edibles. And the second thing is, everyone’s going to Port...
Research | May 10, 2024 |

Emerging opportunity in a growing, high-value dermatological market

The following is a transcription of the above video, and The Market Online has edited it for clarity . Kane Biotech Inc. (TSXV:KNE) , a Canadian-based biotech company engaged in the development and commercialization of products that prevent and remove microbial biof...
Ryan Dhillon | April 11, 2024 |

Can NervGen keep a lid on explosive news?

Speculation of early “evidence” of successful proof-of-concept human trials sparks stock rallies Trial volunteers taking a placebo are offered the real deal in a follow-up trial as a “reward” The company&Clo...
Knox Henderson | March 20, 2024 |

Is this stunning 'evidence' that NervGen has the goods?

This could be the signal that tiny NervGen Pharma Corp. (TSX-V:NGEN; OTCQX:NGENF) is destined to be one of the top performing biotech startup stocks this year. It came in a seemingly innocuous podcast interview about the company’s ongoing Phase 1b/2...
Knox Henderson | February 1, 2024 |

Medicus Pharma advances cancer treatment towards phase II trial

The following is a transcription of the above video, and The Market Herald Canada has edited it for clarity . Our next company is Medicus Pharma Ltd. (TSXV:MDCX) , headquartered in Philadelphia, Pennsylvania. The company is a publicly traded clinical stage, multi-st...
Ryan Dhillon | January 22, 2024 |
1 2 3 4 5 6 7 8 9 10 ...